• Atopic Dermatitis
• Urticaria
• Allergic Contact Dermatitis
• Others

• Corticosteroid
• Calcineurin Inhibitors
• Local Anesthetic
• Antihistamine
• Counterirritant
• Immunosuppressant
• Others
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Chronic Pruritus Market Snapshot
Chapter 4. Global Chronic Pruritus Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8. Global Chronic Pruritus Market Penetration & Growth Prospect Mapping (US$ Mn), 2025-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Epidemiology & patient pool analysis
4.11. Treatment pathway & unmet need mapping
4.12. Pipeline & biologics/targeted therapy landscape
4.13. Reimbursement & access analysis
4.14. Use/impact of AI on Chronic Pruritus Market Industry Trends
Chapter 5. Chronic Pruritus Market Segmentation 1: By Disease Type, Estimates & Trend Analysis
5.1. Market Share by Disease Type, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Disease Type:
5.2.1. Atopic Dermatitis
5.2.2. Urticaria
5.2.3. Allergic Contact Dermatitis
5.2.4. Others
Chapter 6. Chronic Pruritus Market Segmentation 2: By Drug Type, Estimates & Trend Analysis
6.1. Market Share by Drug Type, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Drug Type:
6.2.1. Corticosteroid
6.2.2. Calcineurin Inhibitors
6.2.3. Local Anesthetic
6.2.4. Antihistamine
6.2.5. Counterirritant
6.2.6. Immunosuppressant
6.2.7. Others
Chapter 7. Chronic Pruritus Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. Global Chronic Pruritus Market, Regional Snapshot 2025 & 2035
7.2. North America
7.2.1. North America Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
7.2.1.1. US
7.2.1.2. Canada
7.2.2. North America Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2022-2035
7.2.3. North America Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2022-2035
7.3. Europe
7.3.1. Europe Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
7.3.1.1. Germany
7.3.1.2. U.K.
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe
7.3.2. Europe Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2022-2035
7.3.3. Europe Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2022-2035
7.4. Asia Pacific
7.4.1. Asia Pacific Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
7.4.1.1. India
7.4.1.2. China
7.4.1.3. Japan
7.4.1.4. Australia
7.4.1.5. South Korea
7.4.1.6. Hong Kong
7.4.1.7. Southeast Asia
7.4.1.8. Rest of Asia Pacific
7.4.2. Asia Pacific Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2022-2035
7.4.3. Asia Pacific Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2022-2035
7.5. Latin America
7.5.1. Latin America Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2022-2035
7.5.3. Latin America Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2022-2035
7.6. Middle East & Africa
7.6.1. Middle East & Africa Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2035
7.6.1.1. GCC Countries
7.6.1.2. Israel
7.6.1.3. South Africa
7.6.1.4. Rest of Middle East and Africa
7.6.2. Middle East & Africa Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2022-2035
7.6.3. Middle East & Africa Chronic Pruritus Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2022-2035
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. GlaxoSmithKline plc
8.2.1.1. Business Overview
8.2.1.2. Key Product/Service
8.2.1.3. Financial Performance
8.2.1.4. Geographical Presence
8.2.1.5. Recent Developments with Business Strategy
8.2.2. Galderma
8.2.3. Sanofi
8.2.4. Chugai Pharmaceutical
8.2.5. Mirum Pharmaceuticals
8.2.6. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.